SCHEMBL4361817

SCHEMBL4361817

CC(=O)Nc1cccc(COc2c(Br)cc(C(=O)NCC(=O)O)cc2Br)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRA P10827 4/20 0.52
THRB P10828 4/20 0.52
USP2 O75604 1/20 0.50
SENP5 Q96HI0 1/20 0.50
SENP2 Q9HC62 1/20 0.50
SENP1 Q9P0U3 1/20 0.50
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
RAB9A P51151 2/20 0.47
NPC1 O15118 1/20 0.47
SIRT2 Q8IXJ6 2/20 0.47
SIRT3 Q9NTG7 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.46
PDE5A O76074 1/20 0.46
DHODH Q02127 2/20 0.45
ESR1 P03372 1/20 0.45
NR3C1 P04150 1/20 0.45
PGR P06401 1/20 0.45
NR3C2 P08235 1/20 0.45
AR P10275 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4351576 0.90 THRA (0.53) THRATHRBSENP5SENP2SENP1
SCHEMBL5119979 0.89 MEN1 (0.50) USP2SENP5SENP2SENP1MEN1
SCHEMBL4349556 0.89 THRA (0.52) THRATHRBSENP5SENP2SENP1
SCHEMBL4354874 0.89 THRA (0.53) THRATHRBMEN1KMT2ASMN1; SMN2
SCHEMBL4350209 0.89 SENP5 (0.52) THRATHRBSENP5SENP2SENP1
SCHEMBL4540037 0.87 THRA (0.69) THRATHRBSENP5SENP2SENP1
SCHEMBL4537906 0.86 MEN1 (0.51) THRATHRBMEN1KMT2ARAB9A
SCHEMBL4354703 0.86 THRA (0.42) THRATHRBUSP2SENP5SENP2
SCHEMBL4525410 0.86 THRA (0.40) THRATHRBUSP2SENP5SENP2
SCHEMBL4356831 0.85 THRA (0.58) THRATHRBMEN1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009080835-A1 THYROMIMETRIC COMPOUNDS IN TREATMENT OF DISEASE RELATED TO SONIC HEDGEHOG SIGNALLING KARO BIO AB (SE) 2009-07-02 WO claimed
WO-2009080835-A1 THYROMIMETRIC COMPOUNDS IN TREATMENT OF DISEASE RELATED TO SONIC HEDGEHOG SIGNALLING KARO BIO AB (SE) 2009-07-02 WO disclosed
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor KARO BIO AB (SE) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor TSHR, TRHR, THRA THRA 3/4885THRB 4/4885USP2 4150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.